Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Professor Jacqui Matthews joins Austin Davis Biologics
Professor Jacqui Matthews.

She will take on the role of director of veterinary science.

Professor Jacqui Matthews has been appointed as director of veterinary science for Austin Davis Biologics (ADB), beginning on 14 November 2022.

The company deals in veterinary diagnostics and parasitology research, particularly in equine health. 

In her capacity as director of veterinary science, Professor Matthews will lead research and development activities, and will provide advice and support to clients who use the diagnostic test services through the use of webinars and training activities.

Dr Corrine Austin, founder and managing director of ABD, welcomed Professor Matthews to the team: “We are thrilled that Professor Matthews is joining our family-run veterinary diagnostic company. 

“Her input to ADB’s research programmes, as well as the wider equine parasitology field, is highly valued.”

After originally qualifying as a veterinary surgeon, Professor Matthews moved into the field of academia, and for 25 years has become renowned for her work in equine parasitology.

Professor Matthews is the inventor of the small redworm blood test, and has published over 140 peer-reviewed papers.

Discussing her new position, Professor Matthews said: “I am absolutely delighted to be joining ADB and given this opportunity to support and promote evidence based helminth control in horses in the UK and overseas. 

“I am also really looking forward to bringing more innovative diagnostics to the market to support animal health”.

Dr Austin added: “Not only do we have a busy future research program, but we hold a lot of information that hasn’t yet been published; Jacqui’s new position within ADB will accelerate future research as well dissemination of our existing research data.”

 

Image (C) Austin Davis Biologics

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.